Slingshot members are tracking this event:

Decision on Lilly's (LLY) Olaratumab in Soft Tissue Sarcoma Expected From European Medicines Agency By End of November

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 19, 2016
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Olaratumab, Soft Tissue Sarcoma, European Medicines Agency, Chmp